Search research articles
Contact Us
Filters
Showing results (21-30 of 333) with videos related to
Page
of 34
Sort By:
Journal of Neurochemistry
|
December 20, 2007
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper, Richard Killick, Simon Lovestone
Archives of Neurology
|
November 16, 2011
Clusterin as an Alzheimer biomarker
John Hardy, Rita Guerreiro, Simon Lovestone
Mental Health Today (Brighton, England)
|
August 12, 2010
Giving dementia a voice
Felicity Callard, Simon Lovestone, Megan Pritchard
Frontiers in Neurology
|
December 5, 2015
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Alison L Baird, Sarah Westwood, Simon Lovestone
Biomarker Insights
|
July 7, 2009
Alzheimer's Disease, Diagnosis and the Need for Biomarkers
Claudie Hooper, Simon Lovestone, Ricardo Sainz-Fuertes
Alzheimer'S & Dementia (New York, N. Y.)
|
September 29, 2021
Treatment with TNF-α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease
David M Kern, Simon Lovestone, M Soledad Cepeda
Neuroscience Letters
|
September 10, 2010
β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration
Mirsada Caušević, Umbreen Farooq, Simon Lovestone, et al.
Trends in Neurosciences
|
February 28, 2007
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone, Richard Killick, Marta Di Forti, et al.
Neuroscience Letters
|
February 16, 2007
The Notch-1 intracellular domain is found in sub-nuclear bodies in SH-SY5Y neuroblastomas and in primary cortical neurons
Claudie Hooper, J Paul Chapple, Simon Lovestone, et al.
Journal of Alzheimer'S Disease : JAD
|
May 20, 2011
The impact of a novel apolipoprotein E and amyloid-β protein precursor-interacting protein on the production of amyloid-β
Paul C R Hopkins, Ricardo Sáinz-Fuertes, Simon Lovestone
Page
of 34
Search research articles
Search
Showing results (21-30 of 333) with videos related to
Sort By:
Page
of 34
Journal of Neurochemistry
|
December 20, 2007
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper, Richard Killick, Simon Lovestone
Archives of Neurology
|
November 16, 2011
Clusterin as an Alzheimer biomarker
John Hardy, Rita Guerreiro, Simon Lovestone
Mental Health Today (Brighton, England)
|
August 12, 2010
Giving dementia a voice
Felicity Callard, Simon Lovestone, Megan Pritchard
Frontiers in Neurology
|
December 5, 2015
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Alison L Baird, Sarah Westwood, Simon Lovestone
Biomarker Insights
|
July 7, 2009
Alzheimer's Disease, Diagnosis and the Need for Biomarkers
Claudie Hooper, Simon Lovestone, Ricardo Sainz-Fuertes
Alzheimer'S & Dementia (New York, N. Y.)
|
September 29, 2021
Treatment with TNF-α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease
David M Kern, Simon Lovestone, M Soledad Cepeda
Neuroscience Letters
|
September 10, 2010
β-Amyloid precursor protein and tau protein levels are differently regulated in human cerebellum compared to brain regions vulnerable to Alzheimer's type neurodegeneration
Mirsada Caušević, Umbreen Farooq, Simon Lovestone, et al.
Trends in Neurosciences
|
February 28, 2007
Schizophrenia as a GSK-3 dysregulation disorder
Simon Lovestone, Richard Killick, Marta Di Forti, et al.
Neuroscience Letters
|
February 16, 2007
The Notch-1 intracellular domain is found in sub-nuclear bodies in SH-SY5Y neuroblastomas and in primary cortical neurons
Claudie Hooper, J Paul Chapple, Simon Lovestone, et al.
Journal of Alzheimer'S Disease : JAD
|
May 20, 2011
The impact of a novel apolipoprotein E and amyloid-β protein precursor-interacting protein on the production of amyloid-β
Paul C R Hopkins, Ricardo Sáinz-Fuertes, Simon Lovestone
Page
of 34